secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSMED Inc (INSM)
CIK:        0001104506
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001140361-23-024132
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insmed shareholders approve incentive plan, elect directors, adopt universal proxy bylaws
--------------------------------------------------------------------------------

- Shareholders approved Amended and Restated 2019 Incentive Plan with 101.6M for, 11.0M against.
- Elected Class II directors: E.M. Anderson, C. Desjardins, D.W.J. McGirr (each with ~87-100M for).
- Advisory say-on-pay approved (107.7M for, 5.0M against); future votes every one year (112.5M).
- Ratified Ernst & Young as auditor for FY2023 (118.0M for).
- Bylaws amended to comply with universal proxy rules and set board size by resolution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1104506/000114036123024132/0001140361-23-024132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1104506/000114036123024132/brhc20052827_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-024132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer